Shionogi
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Shionogi
RECRUITINGPhase 1NCT07093580
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
Sponsor: ShionogiEnrolling: 982 locations
Healthy Participants
RECRUITINGPhase 2NCT07214571
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk...
The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for...
Sponsor: ShionogiEnrolling: 19220 locations
Respiratory Syncytial Virus Infections
RECRUITINGPhase 2NCT07123155
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and exploratory clinical efficacy of S-606001 in adult participants with LOPD as an add-on to ERT.
Sponsor: ShionogiEnrolling: 4520 locations
Pompe Disease